All In Biotech

Drug Trial Radar · NCT01106040

Breast and Melanoma Trial With Lymphoseek to Identify Lymph Nodes

A Phase 3, Prospective, Open-Label, Multicenter Comparison Study of Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Patients With Known Melanoma or Breast Cancer Who Are Undergoing Lymph Node Mapping

Last checked: Nov 20, 2026Latest source record: Jun 17, 2013 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

163

Actual

Start

Jun 2010

Primary completion

Apr 2011

Study completion Apr 2011

Sponsor

Lead sponsor
Navidea BiopharmaceuticalsIndustry
Sponsor type
Industry
First posted
Apr 19, 2010

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Diagnostic
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Data from this pivotal clinical trial will be used to support a marketing application (i.e., NDA) of Navidea's Lymphoseek for use in anatomical delineation of lymphoid tissue (nodes) in the lymphatic pathway draining the primary site of a tumor. Multicenter, open-label, within-patient comparative study of Lymphoseek and vital blue dye in the detection of excised lymph nodes in patients with known melanoma and breast cancer. All patients will receive a single dose of 50 µg Lymphoseek radiolabeled with 0.5 or 2.0 mCi Tc 99m and vital blue dye.

Conditions

  • Breast Cancer
  • Melanoma

Interventions

  • LymphoseekDrug

    The total volume of Lymphoseek injection will be between 0.1 - 1.0 mL.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Concordance of Blue Dye and LymphoseekTime frame: Surgery after injections of Lymphoseek and blue dye

Locations

8 sites in 1 country. Site status is shown where the registry gives one.

  • University of Alabama, Birmingham

    Birmingham, Alabama

  • UCSD Moores Cancer Center

    La Jolla, California

  • Califonia Pacific Medical Center

    San Francisco, California

  • John Wayne Cancer Institute

    Santa Monica, California

  • H. Lee Moffitt Cancer Center

    Tampa, Florida

  • University Hospitals Cleveland

    Cleveland, Ohio

  • Breast Care Specialists

    Columbus, Ohio

  • The Ohio State University

    Columbus, Ohio

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.